Live Breaking News & Updates on Corporate Development For Watson

CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday. This prestigious award highlights Mr. McEnany's outstanding accomplishments, unwavering commitment to rare disease patients, dedication to Cat ....

United States , Coral Gables , David Schull Russo , Nancyk Bryan , Patrickj Mcenany , Patrick Mcenany , Exchange Commission , Mary Coleman Catalyst Pharmaceuticals , Catalyst Pharmaceuticals , Humane Society Of Greater Miami , Catalyst Or Company Nasdaq , Watson Pharmaceuticals Inc , Jackson Health Foundation , National Association Of Pharmaceutical Manufacturers , Royce Laboratories Inc , Corporate Development For Watson , Catalyst Pharmaceuticals Inc , Health Canada , Achievement Award , Annual Meeting , Chief Executive Officer , Royce Laboratories , Watson Pharmaceuticals , Vice President , Corporate Development , Vice Chairman ,